Boardroom Alpha
Boardroom Alpha
MLM · Current Report (Form 8-K) · Filed December 19, 2025

Martin Marietta Materials Inc — Current Report (Form 8-K)

Form
8-K
Filed
December 19, 2025
Period
Dec 19, 2025
Ticker
MLM
Accession
0000950157-25-001013
Boardroom Alpha · Filing insights

Martin Marietta extends maturity of its $800M revolving credit facility to Dec 21, 2030 via Amendment No. 4.

About Martin Marietta Materials Inc
Market cap
$34.6B
1Y TSR
+5.7%
3Y TSR
+10.7%
Board grade
C+
Sector
Basic Materials
CEO
C Howard Nye
Last annual meeting: May 14, 2026 · View full Martin Marietta Materials Inc profile →
falseMARTIN MARIETTA MATERIALS INC000091607600009160762023-11-202023-11-20falseMARTIN MARIETTA MATERIALS INC000091607600009160762023-12-212023-12-21falseMartin Marietta Materials Inc.00009160764123 PARKLAKE AVERALEIGHNYSE00009160762024-12-202024-12-20



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549



FORM 8-K



CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 19, 2025



Martin Marietta Materials, Inc.
(Exact name of registrant as specified in its charter)



North Carolina
(State or other jurisdiction of incorporation)
001-12744
(Commission File Number)
56-1848578
(IRS. Employer Identification No.)

4123 Parklake Avenue
Raleigh, North Carolina
(Address of principal executive offices)
 
27612
(Zip Code)

Registrant’s telephone number, including area code: 919 781-4550

Not Applicable
(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class
Trading Symbol
Name of Each Exchange
on Which Registered
Common Stock, $.01 par value per share
MLM
The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





Item 1.01          Entry into a Material Definitive Agreement

On December 19, 2025, Martin Marietta Materials, Inc. (the “Corporation”) entered into a Loan Modification No. 4 and Extension Agreement (the “Amendment”) with JPMorgan Chase Bank, N.A. (“JPMCB”) and the Lenders (as defined in the Amendment) to the Corporation’s $800,000,000 five-year senior unsecured revolving credit facility with JPMCB, as administrative agent, Deutsche Bank Securities Inc., PNC Bank, National Association, Truist Bank and Wells Fargo Bank, National Association, as co-syndication agents and the lenders party thereto (the “Credit Agreement”).

The Amendment amends the Credit Agreement to, among other things, extend the maturity date of the loans advanced under the Credit Agreement to December 21, 2030.

The full text of the Amendment is filed as Exhibit 10.1 hereto and is incorporated herein by reference. The description of the Amendment and Credit Agreement contained herein are qualified in their entirety by the terms of the Amendment and the Credit Agreement.

Item 2.03          Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

The information required by Item 2.03 is included under Item 1.01 “Entry into a Material Definitive Agreement” and that information is incorporated herein by reference.

Item 9.01          Financial Statements and Exhibits

(d) Exhibits
   
     

     
104
 
The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.




SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: December 19, 2025
MARTIN MARIETTA MATERIALS, INC.
   
 
By:
/s/ Bradley D. Kohn
 
   
Name:
Bradley D. Kohn
 
   
Title:
Senior Vice President, General Counsel and Corporate Secretary
 



From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Martin Marietta Materials Inc (MLM)

Reference

Frequently asked questions

When did Martin Marietta Materials Inc file this 8-K?
Martin Marietta Materials Inc (MLM) filed this Current Report (Form 8-K) with the SEC on December 19, 2025. The accession number assigned by EDGAR is 0000950157-25-001013.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Martin Marietta extends maturity of its $800M revolving credit facility to Dec 21, 2030 via Amendment No. 4. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Martin Marietta Materials Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Martin Marietta Materials Inc has filed under CIK 916076, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer